title: The safety and tolerability of newer antiepileptic drugs in children and adolescents.
abstract: Childhood epilepsy continues to be intractable in more than 25% of patients diagnosed with epilepsy. The introduction of new anti-epileptic drugs (AEDs) provides more options for treatment of children with epilepsy. We review the safety and tolerability of seven new AEDs (levetiracetam, lamotrigine, oxcarbazepine, rufinamide, topiramate, vigabatrin and zonisamide) focusing on their side effect profiles and safety in children and adolescents. Many considerations that are specific for children such as the impact of AEDs on the developing brain are not addressed during the development of new AEDs. They are usually approved as adjunctive therapies based upon clinical trials involving adult patients with partial epilepsy. However, 2 of the AEDs reviewed here (rufinamide and vigabatrin) have FDA approval in the U.S. for specific Pediatric epilepsy syndromes, which are discussed below. The Pediatrician or Neurologists decision on the use of a new AED is an evolutionary process largely dependent on the patient characteristics, personal/peer experiences and literature about efficacy and safety profiles of these medications. Evidence based guidelines are limited due to a lack of randomized controlled trials involving pediatric patients for many of these new AEDs.
authors: Department of Pediatric Neurology, University of Texas South Western Medical Center, Dallas, Texas.
authors: Saima
authors: S
authors: Kayani
authors: Deepa
authors: D
authors: Sirsi
keywords: new AEDs; pediatric epilepsy; safety; tolerability
references: Eur J Paediatr Neurol. 2009 Jan;13(1):3-9
references: 18343174
references: Epilepsia. 2000;41(S1):3-9
references: 10768292
references: Drug Saf. 2010 Aug 1;33(8):653-8
references: 20635823
references: Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(6):58-65
references: 20559276
references: J Child Neurol. 2005 Feb;20(2):87-93
references: 15794171
references: J Child Neurol. 2012 Jan;27(1):80-9
references: 21876066
references: Pediatr Neurol. 2009 May;40(5):392-4
references: 19380079
references: Pharmacotherapy. 2011 Mar;31(3):298-311
references: 21361740
references: Turk J Pediatr. 2008 Sep-Oct;50(5):426-31
references: 19102045
references: Clin Neuropharmacol. 2011 Jan-Feb;34(1):39-47
references: 21242744
references: Epilepsy Res. 2008 Dec;82(2-3):124-32
references: 18778916
references: Brain Dev. 2010 Mar;32(3):208-12
references: 19304420
references: Epilepsy Res. 2006 Jun;69(3):273-94
references: 16621450
references: J Child Neurol. 2009 Dec;24(12):1520-5
references: 19955344
references: Neuropsychiatr Dis Treat. 2007 Feb;3(1):3-11
references: 19300535
references: Pharmacotherapy. 2001 Aug;21(8):904-19
references: 11718497
references: Expert Opin Pharmacother. 2007 Aug;8(12):1931-40
references: 17696794
references: Eur J Paediatr Neurol. 2009 Mar;13(2):141-5
references: 18585941
references: J Child Neurol. 2008 Aug;23(8):853-61
references: 18660469
references: Epilepsy Res. 2007 Jul;75(2-3):75-83
references: 17553670
references: Neurology. 2008 May 20;70(21):1950-8
references: 18401024
references: Pharmacotherapy. 2003 Jan;23(1):93-6
references: 12523465
references: Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):45-50
references: 21322825
references: J Child Neurol. 2006 Jan;21(1):82-4
references: 16551461
references: Mayo Clin Proc. 2003 Mar;78(3):359-70
references: 12630590
references: Epilepsy Curr. 2007 May-Jun;7(3):74-6
references: 17520080
references: Epilepsia. 2009 Feb;50(2):163-73
references: 19230067
references: Epilepsy Res. 2011 Aug;95(3):189-99
references: 21684121
references: Epilepsia. 2010 Jul;51(7):1297-304
references: 20384718
references: Br J Clin Pharmacol. 2010 Mar;69(3):314-6
references: 20233205
references: J Child Neurol. 2009 Dec;24(12):1543-6
references: 19773459
references: Epilepsia. 2001 Dec;42(12):1611-3
references: 11879376
references: Brain Dev. 2011 May;33(5):374-8
references: 20797829
references: Pediatr Neurol. 2011 Jun;44(6):439-42
references: 21555055
references: Epilepsy Behav. 2011 Jul;21(3):282-4
references: 21620771
references: No To Hattatsu. 2011 May;43(3):223-7
references: 21638908
references: Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(5 Pt 1):39-44
references: 21322824
references: Epilepsia. 2009 Feb;50(2):195-205
references: 19054414
references: Ann Neurol. 2011 May;69(5):845-54
references: 21246602
references: Drug Saf. 2010 Sep 1;33(9):751-63
references: 20701408
references: Childs Nerv Syst. 2011 Sep;27(9):1425-30
references: 21442269
references: Epilepsy Res. 2010 Jun;90(1-2):151-6
references: 20466520
references: J Child Neurol. 2010 Feb;25(2):182-7
references: 19494356
references: Paediatr Drugs. 2003;5(8):557-73
references: 12895138
references: Paediatr Drugs. 2000 Jul-Aug;2(4):299-330
references: 10946418
references: Epilepsia. 2011 Apr;52 Suppl 2:72-5
references: 21463285
references: J Child Neurol. 2005 Mar;20(3):212-9
references: 15832611
references: Pediatr Neurol. 2010 Oct;43(4):231-5
references: 20837299
references: Brain Dev. 2008 Oct;30(9):549-55
references: 18328657
references: Paediatr Drugs. 2011 Apr 1;13(2):97-106
references: 21351809
references: Epilepsia. 2011 Mar;52(3):e4-6
references: 21395567
references: Pediatr Neurol. 2006 May;34(5):351-4
references: 16647993
references: Epilepsy Behav. 2008 Oct;13(3):557-9
references: 18647662
references: Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):608-18
references: 21351182
references: Expert Opin Drug Saf. 2007 May;6(3):241-50
references: 17480174
references: Epilepsia. 2010 Dec;51(12):2423-31
references: 21070215
references: Eur J Paediatr Neurol. 2011 Nov;15(6):527-31
references: 21703891
references: J Child Neurol. 2001 Aug;16(8):622-3
references: 11510941
references: Eur J Emerg Med. 2010 Aug;17(4):228-9
references: 19820401
references: Seizure. 2010 Jan;19(1):31-5
references: 19942456
references: Seizure. 2000 Mar;9(2):137-41
references: 10845739
references: J Pediatr Neurosci. 2010 Jan;5(1):85-6
references: 21042521
references: J Paediatr Child Health. 2003 Aug;39(6):416-9
references: 12919493
references: Brain Dev. 2003 Jan;25(1):51-6
references: 12536034